It is our unwavering commitment to unite against the looming health threats posed by vector-borne diseases in the Balkan region. With a clear understanding of the detrimental impact these diseases can have on public health, we stand resolute in our mission to combat and mitigate the spread of vector-borne illnesses.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Novi Sad, Select... 21000, Rs
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.bavbd.org/
- HQ
- Novi Sad, Select...
- Competitors
- Udruženje mikrobiologa Srbije, Институт за јавно здравје на Република С. Македонија, Vita S Polyclinic, European Movement in Albania, EBSA - European Biosafety Association, Southeastern Center of Excellence in Vector Borne Diseases, European Mosquito Control Association EMCA, MLÉKÁRNA KLATOVY, s.r.o., J'achète en CCHF, Eurosurveillance.
Balkan Association For Vector-Borne Diseases (Bavbd) Questions
Balkan Association For Vector-Borne Diseases (Bavbd)'s website is https://www.bavbd.org/
Balkan Association For Vector-Borne Diseases (Bavbd)'s LinkedIn profile is https://rs.linkedin.com/company/bavbd
Balkan Association For Vector-Borne Diseases (Bavbd) has
1 employees.
View email and phone details for 1
employees at Balkan Association For Vector-Borne Diseases (Bavbd).
Balkan Association For Vector-Borne Diseases (Bavbd)'s industry is
Biotechnology Research
Balkan Association For Vector-Borne Diseases (Bavbd)'s top competitors are
Udruženje Mikrobiologa Srbije,
Институт За Јавно Здравје На Република С. Македонија,
Vita S Polyclinic,
European Movement In Albania,
Ebsa - European Biosafety Association,
Southeastern Center Of Excellence In Vector Borne Diseases,
European Mosquito Control Association Emca,
Mlékárna Klatovy, S.r.o.,
J'achète En Cchf,
Eurosurveillance.
Balkan Association For Vector-Borne Diseases (Bavbd)'s categories are Biotechnology Research
Balkan Association For Vector-Borne Diseases (Bavbd)'s founding year is 2024
